{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:45:34Z","timestamp":1787010334015,"version":"build-2736575974"},"reference-count":59,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>\n                      This systematic review and meta-analysis compared the diagnostic performance of MRI, [\n                      <jats:sup>18<\/jats:sup>\n                      F]FDG-PET\/CT, and [\n                      <jats:sup>18<\/jats:sup>\n                      F]FDG-PET\/MRI in detecting focal bone lesions and bone marrow infiltration in the initial staging of patients with multiple myeloma (MM) who underwent both MRI and [\n                      <jats:sup>18<\/jats:sup>\n                      F]FDG-PET\/CT or [\n                      <jats:sup>18<\/jats:sup>\n                      F]FDG-PET\/MRI studies.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and Methods:<\/jats:title>\n                    <jats:p>\n                      A systematic literature search was conducted across PubMed, Embase, and Cochrane databases, including studies comparing the performance of MRI (WB-MRI or spine\/pelvis MRI), [\n                      <jats:sup>18<\/jats:sup>\n                      F]FDG-PET\/CT, and\/or [\n                      <jats:sup>18<\/jats:sup>\n                      F]FDG-PET\/MRI in the same patients for MM initial staging. Pooled sensitivities and concordance between imaging modalities were analyzed using R (package META-R). Heterogeneity and bias were assessed with the QUADAS-C tool.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Twenty studies (published between 2007 and 2025) using the international MM diagnostic criteria as a reference standard met the inclusion criteria. Of these, 13 (n=742) compared per-patient sensitivity of [\n                      <jats:sup>18<\/jats:sup>\n                      F]FDG-PET\/CT and MRI, and 4 (n=224) compared MRI and [\n                      <jats:sup>18<\/jats:sup>\n                      F]FDG-PET\/MRI. Pooled sensitivities were 0.807 (95% CI: 0.74\u20130.86) for [\n                      <jats:sup>18<\/jats:sup>\n                      F]FDG-PET\/CT (with significant heterogeneity) versus 0.914 (95% CI: 0.88\u20130.94) for MRI (0.906 for spine\/pelvis MRI and 0.920 for WB-MRI) (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.001 for meta-regression analysis). Using contingency tables, 83% (599\/721) of included patients had concordant [\n                      <jats:sup>18<\/jats:sup>\n                      F]FDG-PET\/CT and MRI results, while 14% (101\/721) patients had negative [\n                      <jats:sup>18<\/jats:sup>\n                      F]FDG-PET\/CT and positive MRI with significant differences between the 2 techniques for the paired sample analysis (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.001). The pooled sensitivity of the 4 studies including [\n                      <jats:sup>18<\/jats:sup>\n                      F]FDG-PET\/MRI was 0.944 (95% CI: 0.88\u20130.98). Consensus definitions for specificity in MM imaging should be standardized across studies.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>\n                      This systematic review and comparative meta-analysis demonstrates superior sensitivity of WB-MRI compared with [\n                      <jats:sup>18<\/jats:sup>\n                      F]FDG-PET\/CT for initial staging of MM patients. Future international guidelines might prioritize MRI and [\n                      <jats:sup>18<\/jats:sup>\n                      F]FDG-PET\/MRI for staging of MM patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Registration<\/jats:title>\n                    <jats:p>PROSPERO CRD42024564937.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/rlu.0000000000006048","type":"journal-article","created":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T19:00:06Z","timestamp":1752260406000},"page":"1006-1015","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Comparison of MRI, [18F]FDG-PET\/CT, and [18F]FDG-PET\/MRI for Initial Staging of Multiple Myeloma"],"prefix":"10.1097","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8212-7790","authenticated-orcid":false,"given":"Mickael","family":"Tordjman","sequence":"first","affiliation":[{"name":"Department of Diagnostic, Molecular and Interventional Radiology, Biomedical Engineering & Imaging Institute, Mount Sinai Health System, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0619-5868","authenticated-orcid":false,"given":"Murat","family":"Yuce","sequence":"additional","affiliation":[{"name":"Department of Diagnostic, Molecular and Interventional Radiology, Biomedical Engineering & Imaging Institute, Mount Sinai Health System, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1924-866X","authenticated-orcid":false,"given":"Amine","family":"Geahchan","sequence":"additional","affiliation":[{"name":"Department of Diagnostic, Molecular and Interventional Radiology, Biomedical Engineering & Imaging Institute, Mount Sinai Health System, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8483-3816","authenticated-orcid":false,"given":"Giuseppe","family":"Petralia","sequence":"additional","affiliation":[{"name":"Division of Radiology, IEO European Institute of Oncology IRCCS"},{"name":"Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8071-6513","authenticated-orcid":false,"given":"Roberto C.","family":"Delgado Bolton","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Imaging (Radiology) and Nuclear Medicine, University Hospital San Pedro and Centre for Biomedical Research of La Rioja, Logro\u00f1o"},{"name":"Servicio C\u00e1ntabro de Salud, Santander, Cantabria, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Diagnostic, Molecular and Interventional Radiology, Biomedical Engineering & Imaging Institute, Mount Sinai Health System, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amish H.","family":"Doshi","sequence":"additional","affiliation":[{"name":"Department of Diagnostic, Molecular and Interventional Radiology, Biomedical Engineering & Imaging Institute, Mount Sinai Health System, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8205-7209","authenticated-orcid":false,"given":"Ian","family":"Bolger","sequence":"additional","affiliation":[{"name":"Department of Diagnostic, Molecular and Interventional Radiology, Biomedical Engineering & Imaging Institute, Mount Sinai Health System, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyan","family":"Mei","sequence":"additional","affiliation":[{"name":"Department of Diagnostic, Molecular and Interventional Radiology, Biomedical Engineering & Imaging Institute, Mount Sinai Health System, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1322-0710","authenticated-orcid":false,"given":"Laurent","family":"Dercle","sequence":"additional","affiliation":[{"name":"Department of Radiology, Columbia University Irving Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0272-0733","authenticated-orcid":false,"given":"Himanshu","family":"Joshi","sequence":"additional","affiliation":[{"name":"Department of Population Health Science and Policy, Icahn School of Medicine"},{"name":"Institute for Health Care Delivery Science, Mount Sinai Health System at Mount Sinai"},{"name":"Tisch Cancer Institute, Biostatistics Shared Resource Facility, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0557-9379","authenticated-orcid":false,"given":"Christina","family":"Messiou","sequence":"additional","affiliation":[{"name":"Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dow-Mu","family":"Koh","sequence":"additional","affiliation":[{"name":"Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Parekh","sequence":"additional","affiliation":[{"name":"Departments of Medicine, Hematology and Medical Oncology"},{"name":"Oncological Sciences"},{"name":"Tisch Cancer Institute"},{"name":"Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6409-1333","authenticated-orcid":false,"given":"Bachir","family":"Taouli","sequence":"additional","affiliation":[{"name":"Department of Diagnostic, Molecular and Interventional Radiology, Biomedical Engineering & Imaging Institute, Mount Sinai Health System, New York, NY"},{"name":"Tisch Cancer Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,7,8]]},"reference":[{"key":"R1-20251009","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol"},{"key":"R2-20251009","doi-asserted-by":"crossref","first-page":"884","DOI":"10.2214\/AJR.12.9653","article-title":"Evolving role of FDG PET\/CT in multiple myeloma imaging and management","volume":"200","author":"Agarwal","year":"2013","journal-title":"Am J Roentgenol"},{"key":"R3-20251009","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1148\/rg.2019180096","article-title":"Whole-body imaging of multiple myeloma: diagnostic criteria","volume":"39","author":"Ormond Filho","year":"2019","journal-title":"RadioGraphics"},{"key":"R4-20251009","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.3390\/cancers12113155","article-title":"Whole-body functional MRI and PET\/MRI in multiple myeloma","volume":"12","author":"Mul\u00e9","year":"2020","journal-title":"Cancer"},{"key":"R5-20251009","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1007\/s00259-024-06668-z","article-title":"Artificial intelligence-based, volumetric assessment of the bone marrow metabolic activity in [18F]FDG PET\/CT predicts survival in multiple myeloma","volume":"51","author":"Sachpekidis","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R6-20251009","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1182\/blood-2018-04-842880","article-title":"The presence of large focal lesions is a strong independent prognostic factor in multiple myeloma","volume":"132","author":"Rasche","year":"2018","journal-title":"Blood"},{"key":"R8-20251009","doi-asserted-by":"crossref","first-page":"e302","DOI":"10.1016\/S1470-2045(19)30309-2","article-title":"International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders","volume":"20","author":"Hillengass","year":"2019","journal-title":"Lancet Oncol"},{"key":"R9-20251009","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00256-022-04119-0","article-title":"Diffusion-weighted imaging (DWI) in diagnosis, staging, and treatment response assessment of multiple myeloma: a systematic review and meta-analysis","volume":"52","author":"Torkian","year":"2023","journal-title":"Skeletal Radiol"},{"key":"R10-20251009","doi-asserted-by":"crossref","first-page":"9879","DOI":"10.7314\/APJCP.2014.15.22.9879","article-title":"A systematic review of MRI, scintigraphy, FDG-PET and PET\/CT for diagnosis of multiple myeloma related bone disease--which is best?","volume":"15","author":"Weng","year":"2014","journal-title":"Asian Pac J Cancer Prev APJCP"},{"key":"R11-20251009","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.critrevonc.2018.02.012","article-title":"Comparison of whole body magnetic resonance imaging (WBMRI) to whole body computed tomography (WBCT) or 18F-fluorodeoxyglucose positron emission tomography\/CT (18F-FDG PET\/CT) in patients with myeloma: systematic review of diagnostic performance","volume":"124","author":"Gariani","year":"2018","journal-title":"Crit Rev Oncol Hematol"},{"key":"R12-20251009","doi-asserted-by":"crossref","first-page":"602","DOI":"10.2214\/AJR.21.26381","article-title":"Comparative performance of whole-body MRI and FDG PET\/CT in evaluation of multiple myeloma treatment response: systematic review and meta-analysis","volume":"218","author":"Rama","year":"2022","journal-title":"Am J Roentgenol"},{"key":"R13-20251009","first-page":"706","article-title":"Comparison of [18F]FDG PET\/CT and MRI for treatment response assessment in multiple myeloma: a meta-analysis","volume":"11","author":"Yokoyama","year":"2021","journal-title":"Diagn Basel Switz"},{"key":"R14-20251009","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1200\/JCO.2017.72.2975","article-title":"Prospective evaluation of magnetic resonance imaging and [18F]Fluorodeoxyglucose positron emission tomography-computed tomography at diagnosis and before maintenance therapy in symptomatic patients with multiple myeloma included in the IFM\/DFCI 2009 trial: results of the IMAJEM study","volume":"35","author":"Moreau","year":"2017","journal-title":"J Clin Oncol"},{"key":"R15-20251009","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1007\/s00277-020-04265-2","article-title":"Prospective comparison of 18-FDG PET\/CT and whole-body diffusion-weighted MRI in the assessment of multiple myeloma","volume":"99","author":"Mesguich","year":"2020","journal-title":"Ann Hematol"},{"key":"R16-20251009","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1002\/jmri.26848","article-title":"MRI and PET\/MRI in hematologic malignancies","volume":"51","author":"Mayerhoefer","year":"2020","journal-title":"J Magn Reson Imaging"},{"key":"R17-20251009","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jclinepi.2016.01.021","article-title":"PRESS peer review of electronic search strategies: 2015 guideline statement","volume":"75","author":"McGowan","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"R18-20251009","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/hon.2600","article-title":"Dual-tracer PET\/CT scan after injection of combined [18F]NaF and [18F]FDG outperforms MRI in the detection of myeloma lesions","volume":"37","author":"Withofs","year":"2019","journal-title":"Hematol Oncol"},{"key":"R19-20251009","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Intern Med"},{"key":"R20-20251009","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.7326\/M21-2234","article-title":"QUADAS-C: a tool for assessing risk of bias in comparative diagnostic accuracy studies","volume":"174","author":"Yang","year":"2021","journal-title":"Ann Intern Med"},{"key":"R21-20251009","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1148\/radiol.2019181949","article-title":"Guidelines for acquisition, interpretation, and reporting of whole-body MRI in myeloma: myeloma response assessment and diagnosis system (MY-RADS)","volume":"291","author":"Messiou","year":"2019","journal-title":"Radiology"},{"key":"R22-20251009","doi-asserted-by":"crossref","first-page":"e210048","DOI":"10.1148\/rycan.2021210048","article-title":"Prospective evaluation of whole-body MRI versus FDG PET\/CT for lesion detection in participants with myeloma","volume":"3","author":"Messiou","year":"2021","journal-title":"Radiol Imaging Cancer"},{"key":"R23-20251009","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1007\/s00330-021-08388-6","article-title":"Optimization of whole-body 2-[18F]FDG-PET\/MRI imaging protocol for the initial staging of patients with myeloma","volume":"32","author":"Burns","year":"2022","journal-title":"Eur Radiol"},{"key":"R24-20251009","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/00365510701666031","article-title":"McNemar chi2 test revisited: comparing sensitivity and specificity of diagnostic examinations","volume":"68","author":"Trajman","year":"2008","journal-title":"Scand J Clin Lab Invest"},{"key":"R25-20251009","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3324\/haematol.10554","article-title":"A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma","volume":"92","author":"Zamagni","year":"2007","journal-title":"Haematologica"},{"key":"R26-20251009","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2967\/jnumed.107.045641","article-title":"18F-FDG PET\/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma","volume":"49","author":"Fonti","year":"2008","journal-title":"J Nucl Med"},{"key":"R27-20251009","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s11604-018-0738-z","article-title":"Diagnostic performance of 18F-FDG PET\/CT and whole-body MRI before and early after treatment of multiple myeloma: a prospective comparative study","volume":"36","author":"Basha","year":"2018","journal-title":"Jpn J Radiol"},{"key":"R28-20251009","doi-asserted-by":"crossref","first-page":"6438","DOI":"10.1007\/s00330-023-09593-1","article-title":"Hybrid simultaneous whole-body 2-[18F]FDG-PET\/MRI imaging in newly diagnosed multiple myeloma: first diagnostic performance and clinical added value results","volume":"33","author":"Jamet","year":"2023","journal-title":"Eur Radiol"},{"key":"R29-20251009","first-page":"303","article-title":"Diagnostic value of WB-DWI versus 18F-FDG PET\/CT for the detection of multiple myeloma","volume":"60","author":"Zhang","year":"2023","journal-title":"Indian J Cancer"},{"key":"R30-20251009","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1007\/s11547-013-0946-7","article-title":"Whole-body MRI and PET\/CT in multiple myeloma patients during staging and after treatment: personal experience in a longitudinal study","volume":"118","author":"Cascini","year":"2013","journal-title":"Radiol Med (Torino)"},{"key":"R31-20251009","first-page":"469","article-title":"Comparison of (18)F-FDG PET\/CT and PET\/MRI in patients with multiple myeloma","volume":"5","author":"Sachpekidis","year":"2015","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"R32-20251009","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1007\/s00259-020-05182-2","article-title":"Comparison of the diagnostic performance and impact on management of 18F-FDG PET\/CT and whole-body MRI in multiple myeloma","volume":"48","author":"Westerland","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R33-20251009","doi-asserted-by":"crossref","first-page":"514","DOI":"10.2214\/AJR.18.20989","article-title":"Comparison of whole-body DWI and 18F-FDG PET\/CT for detecting intramedullary and extramedullary lesions in multiple myeloma","volume":"213","author":"Chen","year":"2019","journal-title":"AJR Am J Roentgenol"},{"key":"R34-20251009","doi-asserted-by":"crossref","first-page":"6136","DOI":"10.1007\/s00330-021-07687-2","article-title":"Total diffusion volume in MRI vs. total lesion glycolysis in PET\/CT for tumor volume evaluation of multiple myeloma","volume":"31","author":"Terao","year":"2021","journal-title":"Eur Radiol"},{"key":"R35-20251009","first-page":"2058460117738809","article-title":"A prospective study comparing whole-body skeletal X-ray survey with 18F-FDG-PET\/CT, 18F-NaF-PET\/CT and whole-body MRI in the detection of bone lesions in multiple myeloma patients","volume":"6","author":"Dyrberg","year":"2017","journal-title":"Acta Radiol Open"},{"key":"R36-20251009","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1182\/blood-2017-03-774422","article-title":"Low expression of hexokinase-2 is associated with false-negative FDG\u2013positron emission tomography in multiple myeloma","volume":"130","author":"Rasche","year":"2017","journal-title":"Blood"},{"key":"R37-20251009","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/RLU.0000000000003512","article-title":"Agreement between 18F-FDG PET\/CT and whole-body magnetic resonance compared with skeletal survey for initial staging and response at end-of-treatment evaluation of patients with multiple myeloma","volume":"46","author":"G\u00f3mez Le\u00f3n","year":"2021","journal-title":"Clin Nucl Med"},{"key":"R38-20251009","doi-asserted-by":"crossref","first-page":"590","DOI":"10.47102\/annals-acadmedsg.2022414","article-title":"Clinical utility of PET\/MRI in multiple myeloma","volume":"52","author":"Soekojo","year":"2023","journal-title":"Ann Acad Med Singapore"},{"key":"R39-20251009","article-title":"Prognostic value of [18F]fluorodeoxyglucose-PET\/MRI(CT) novel inter pretation criteria (IMPeTUs) in multiple myeloma","author":"Zhang","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R40-20251009","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4065\/78.1.21","article-title":"Review of 1027 patients with newly diagnosed multiple myeloma","volume":"78","author":"Kyle","year":"2003","journal-title":"Mayo Clin Proc"},{"key":"R41-20251009","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1007\/s00259-023-06406-x","article-title":"International EANM-SNMMI-ISMRM consensus recommendation for PET\/MRI in oncology","volume":"50","author":"Veit-Haibach","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R42-20251009","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s13244-023-01498-3","article-title":"Image quality in whole-body MRI using the MY-RADS protocol in a prospective multi-centre multiple myeloma study","volume":"14","author":"Keaveney","year":"2023","journal-title":"Insights Imaging"},{"key":"R43-20251009","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","article-title":"FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0","volume":"42","author":"Boellaard","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R44-20251009","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1007\/s00330-012-2600-5","article-title":"Comparative diagnostic performance of 18F-FDG PET\/CT versus whole-body MRI for determination of remission status in multiple myeloma after stem cell transplantation","volume":"23","author":"Derlin","year":"2013","journal-title":"Eur Radiol"},{"key":"R45-20251009","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.mri.2020.10.005","article-title":"Characterising spatial heterogeneity of multiple myeloma in high resolution by whole body magnetic resonance imaging: towards macro-phenotype driven patient management","volume":"75","author":"Latifoltojar","year":"2021","journal-title":"Magn Reson Imaging"},{"key":"R46-20251009","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/leu.2015.291","article-title":"18F-FDG PET\/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active disease","volume":"30","author":"Zamagni","year":"2016","journal-title":"Leukemia"},{"key":"R47-20251009","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/ajh.23258","article-title":"Diffuse pattern of bone marrow involvement on magnetic resonance imaging is associated with high risk cytogenetics and poor outcome in newly diagnosed, symptomatic patients with multiple myeloma: a single center experience on 228 patients","volume":"87","author":"Moulopoulos","year":"2012","journal-title":"Am J Hematol"},{"key":"R48-20251009","doi-asserted-by":"crossref","first-page":"116957","DOI":"10.1016\/j.bone.2023.116957","article-title":"The role of conventional and novel PET radiotracers in assessment of myeloma bone disease","volume":"179","author":"Zirakchian Zadeh","year":"2024","journal-title":"Bone"},{"key":"R49-20251009","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.3390\/diagnostics13091570","article-title":"Multitracer PET\/CT with [18F]Fluorodeoxiglucose and [18F]Fluorocholine in the initial staging of multiple myeloma patients applying the impetus criteria: a pilot study","volume":"13","author":"Garrastachu Zumar\u00e1n","year":"2023","journal-title":"Diagnostics"},{"key":"R50-20251009","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1158\/1078-0432.CCR-23-2130","article-title":"CD46-targeted theranostics for PET and 225Ac-Radiopharmaceutical Therapy of Multiple Myeloma","volume":"30","author":"Wadhwa","year":"2024","journal-title":"Clin Cancer Res"},{"key":"R51-20251009","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3390\/tomography8010024","article-title":"Comparison of [68Ga]-FAPI PET\/CT and [18F]-FDG PET\/CT in multiple myeloma: clinical experience","volume":"8","author":"Elboga","year":"2022","journal-title":"Tomography"},{"key":"R52-20251009","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.3390\/cancers12092537","article-title":"Spatial distribution of focal lesions in whole-body MRI and influence of MRI protocol on staging in patients with smoldering multiple myeloma according to the new SLiM-CRAB-criteria","volume":"12","author":"Wennmann","year":"2020","journal-title":"Cancers"},{"key":"R53-20251009","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.3892\/ol.2017.5723","article-title":"Whole\u2011body low\u2011dose computed tomography in multiple myeloma staging: superior diagnostic performance in the detection of bone lesions, vertebral compression fractures, rib fractures and extraskeletal findings compared to radiography with similar radiation exposure","volume":"13","author":"Lambert","year":"2017","journal-title":"Oncol Lett"},{"key":"R54-20251009","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00256-008-0607-4","article-title":"Accuracy of whole-body low-dose multidetector CT (WBLDCT) versus skeletal survey in the detection of myelomatous lesions, and correlation of disease distribution with whole-body MRI (WBMRI)","volume":"38","author":"Gleeson","year":"2009","journal-title":"Skeletal Radiol"},{"key":"R56-20251009","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.ejrad.2014.02.008","article-title":"Sensitivity of whole-body CT and MRI versus projection radiography in the detection of osteolyses in patients with monoclonal plasma cell disease","volume":"83","author":"Wolf","year":"2014","journal-title":"Eur J Radiol"},{"key":"R57-20251009","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1007\/s00256-024-04723-2","article-title":"Present and future of whole-body MRI in metastatic disease and myeloma: how and why you will do it","volume":"53","author":"Lecouvet","year":"2024","journal-title":"Skeletal Radiol"},{"key":"R58-20251009","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1093\/bjr\/tqae110","article-title":"National myeloma patient survey shows continuing inappropriate imaging and geographical inequalities","volume":"97","author":"Quinn","year":"2024","journal-title":"Br J Radiol"},{"key":"R59-20251009","doi-asserted-by":"crossref","first-page":"20180462","DOI":"10.1259\/bjr.20180462","article-title":"National survey of imaging practice for suspected or confirmed plasma cell malignancies","volume":"91","author":"Westerland","year":"2018","journal-title":"Br J Radiol"},{"key":"R61-20251009","doi-asserted-by":"crossref","first-page":"7985","DOI":"10.1007\/s00330-024-10883-5","article-title":"Image quality of whole-body diffusion MR images comparing deep-learning accelerated and conventional sequences","volume":"34","author":"Ponsiglione","year":"2024","journal-title":"Eur Radiol"},{"key":"R62-20251009","doi-asserted-by":"crossref","first-page":"e200279","DOI":"10.1148\/ryai.2021200279","article-title":"Accelerating whole-body diffusion-weighted MRI with deep learning-based denoising image filters","volume":"3","author":"Zormpas-Petridis","year":"2021","journal-title":"Radiol Artif Intell"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006048","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:04:10Z","timestamp":1760025850000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006048"}},"subtitle":["A Systematic Review and Meta-analysis"],"short-title":[],"issued":{"date-parts":[[2025,7,8]]},"references-count":59,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000006048","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,8]]},"assertion":[{"value":"2025-04-22","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-05","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}